Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1986 Aug 1;164(2):383-92.
doi: 10.1084/jem.164.2.383.

Terminal maturation of resting B cells by proliferation-independent B cells differentiation factors

Terminal maturation of resting B cells by proliferation-independent B cells differentiation factors

L Mayer. J Exp Med. .

Abstract

Using response to four different BCDF preparations as a model of B cell maturation, we have shown that induction of B cell proliferation abrogates terminal maturation of these cells. In fact, response to some BCDFs can occur in the presence of inhibitors of DNA replication, suggesting that there are proliferation-independent as well as proliferation-dependent BCDFs. These findings cannot be explained by changes in the kinetics of the BCDF response, nor can they be reversed by repletion of media or changing cell densities. Proliferation-independent BCDFs appear to exert their effects on dense, resting 4F2- B cells rather than more activated B cells. This is in contrast to B cell differentiation signals of IL-2 alone or SAC and IL-2 in concert. These data suggest that the current models of B cell activation and maturation may require some reorganization, relegating the proliferative phase of B cell maturation to a lesser role. In addition, evidence is provided for the fact that the resting B cell may have the full complement of receptors for BCDF as well as BCGF and BCPF and may help account for the inherent nonspecificity of the immune response.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Exp Med. 1978 Dec 1;148(6):1570-8 - PubMed
    1. Annu Rev Immunol. 1983;1:307-33 - PubMed
    1. Eur J Immunol. 1980 Sep;10(9):679-85 - PubMed
    1. J Immunol. 1981 Apr;126(4):1409-14 - PubMed
    1. J Exp Med. 1983 Sep 1;158(3):822-35 - PubMed

Substances